From: Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
 |  | All (n = 127) | HBV (n = 89) | HCV (n = 38) | P value †|
---|---|---|---|---|---|
Gender | |||||
 | Male | 115 (90%) | 85 (95%) | 30 (79%) | p = 0.007 |
 | Female | 12 (10%) | 4 (5%) | 8 (21%) |  |
Race | |||||
 | Asian | 82 (65%) | 80 (90%) | 2 (5%) | p < 0.001 |
 | Non-Asian | 45 (35%) | 9 (10%) | 36 (95%) |  |
Age | |||||
 | Median | 53 | 50 | 58 | NS |
 | Range | 21-79 | 21-75 | 47-79 |  |
 | Distribution |  |  |  |  |
 | 21-30 | 5 (4%) | 5 (6%) | 0 (0%) |  |
 | 31-40 | 18 (14%) | 18 (20%) | 0 (0%) | p < 0.001 ‡ |
 | 41-50 | 23 (18%) | 21 (24%) | 2 (5%) |  |
 | 51-60 | 50 (39%) | 28 (31%) | 22 (58%) |  |
 | >60 | 31 (24%) | 17 (19%) | 14 (37%) |  |
Comorbidities | |||||
 | Mean ± S.D | 1.6 ± 1.6 | 1.0 ± 1.1 | 2.9 ± 1.5 | p < 0.001 |
Alcohol abuse | |||||
 |  | 18 (15%) | 6 (7%) | 12 (32%) | p < 0.001 |
HIV coinfection | |||||
 |  | 8 (6%) | 1 (1%) | 7 (13%) | p < 0.001 |
Cirrhosis state in the non-neoplastic liver (n = 119) | |||||
 | Non-cirrhosis | 34 (29%) | 34 (40%) | 0 (0%) | p < 0.001 |
 | Cirrhosis | 85 (71%) | 50 (60%) | 35 (100%) |  |
AFP levels (n = 122) | |||||
 | Median | 137 | 1000 | 37 | p = 0.002 |
 | Range | 3-871,485 | 3-871,485 | 4-59,739 |  |
 | Distribution |  |  |  |  |
 | ≤ 9 | 20 (16%) | 13 (15%) | 7 (19%) | NS * |
 | 9-20 | 10 (8%) | 7 (8%) | 3 (8%) | NS * |
 | 20-100 | 27 (22%) | 10 (12%) | 17 (46%) | p < 0.001 * |
 | 100-1,000 | 15 (12%) | 11 (13%) | 4 (11%) | p < 0.001 * |
 | 1,000-10,000 | 27 (22%) | 23 (27%) | 4 (11%) | p = 0.01 * |
 | >10,000 | 23 (19%) | 21 (25%) | 2 (5%) |  |